Veronika Jekerle European Medicines Agency

Veronika Jekerle obtained a pharmacy degree from University of Marburg, Germany (2001) and PhD in Molecular pharmacology, drug discovery from the University of Bonn, Germany and the University of Toronto, Canada. She joined the European Medicines Agency in 2006 and has held various roles including Product Team Lead for Biological medicinal product, Vaccines, ATMPs and Biosimilar applications; Quality Specialist with focus on Advanced Therapies, recombinant proteins including mABs, biosimilars and vaccines, Scientific Secretary to the Biologics Working Party (BWP – 1014 – 2020) and lead of regulatory science activities including prior knowledge flexibility in CMC requirements for PRIME and scientific guidance development of ATMPs, vaccines and Biosimilars. Since March 2020, Veronika is leading the Pharmaceutical Quality Office, responsible for the scientific oversight and management of the pharmaceutical quality of human medicines throughout their life-cycle in the context of the benefit risk assessment.